Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation and Depletion (2017 - 2025)

Historic Depreciation and Depletion for Rockwell Medical (RMTI) over the last 9 years, with Q3 2025 value amounting to $400000.0.

  • Rockwell Medical's Depreciation and Depletion changed 0.0% to $400000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.6 million for FY2024, which is 3333.33% up from last year.
  • Per Rockwell Medical's latest filing, its Depreciation and Depletion stood at $400000.0 for Q3 2025, which was down 0.0% from $400000.0 recorded in Q2 2025.
  • Rockwell Medical's 5-year Depreciation and Depletion high stood at $400000.0 for Q3 2023, and its period low was $100000.0 during Q3 2021.
  • For the 5-year period, Rockwell Medical's Depreciation and Depletion averaged around $272000.0, with its median value being $200000.0 (2021).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first tumbled by 5000.0% in 2021, then soared by 30000.0% in 2023.
  • Quarter analysis of 5 years shows Rockwell Medical's Depreciation and Depletion stood at $168000.0 in 2021, then grew by 19.05% to $200000.0 in 2022, then soared by 100.0% to $400000.0 in 2023, then changed by 0.0% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025.
  • Its Depreciation and Depletion was $400000.0 in Q3 2025, compared to $400000.0 in Q2 2025 and $400000.0 in Q1 2025.